Medicine Description endlixaban 2.5 mg
endlixaban 2.5 mg tablets is a medication that functions as a direct oral anticoagulant. Its primary mechanism of action involves the selective inhibition of Factor Xa, an essential component in the coagulation cascade. By binding to both free and clot-bound Factor Xa, apixaban effectively disrupts the conversion of prothrombin to thrombin, subsequently preventing the formation of fibrin clots. This action reduces the likelihood of thrombus formation in patients at risk of thromboembolic events, thereby providing a therapeutic benefit in various clinical scenarios, such as atrial fibrillation and venous thromboembolism.
Indications and Uses of endlixaban 2.5 mg tablets
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT).
- Prevention of recurrent DVT following initial treatment.
- Treatment of pulmonary embolism (PE).
- Prevention of PE in patients undergoing hip or knee replacement surgery.
Side Effects of endlixaban 2.5 mg tablets
- Bleeding complications, including serious and potentially life-threatening hemorrhages.
- Gastrointestinal disturbances such as nausea and abdominal pain.
- Hematoma at the injection site (if applicable).
- Allergic reactions, including rash or itching.
- Elevated liver enzymes in some patients.
Storage and Handling
Store endlixaban tablets at room temperature, away from moisture and heat. Keep them in their original container and out of reach of children.
Patient Advice and Precautions
Patients should be counseled about the risk of bleeding and advised to report any unusual bruising, bleeding, or signs of an allergic reaction. It is essential to inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements, as these may interact with endlixaban. Regular monitoring and follow-up appointments are important to assess treatment efficacy and safety.